comparemela.com
Home
Live Updates
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit - Akari Therapeutics (NASDAQ:AKTX) : comparemela.com
Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Placement Financing, Company Also Receives $2.5 Million U.K. R&D Tax Credit - Akari Therapeutics (NASDAQ:AKTX)
BOSTON and LONDON, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX) ("Akari" or the "Company"), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory
Related Keywords
United States
,
United Kingdom
,
London
,
City Of
,
Boston
,
Massachusetts
,
Ray Prudo
,
Eliza Schleifstein
,
Mike Moyer
,
Rachelle Jacques
,
Exchange Commission
,
Akari Therapeutics Plc
,
European Commission
,
Paulson Investment Company
,
Akari Chairman
,
American Depository Shares
,
Investment Company
,
Securities Act
,
Orphan Drug
,
Fast Track
,
Rare Pediatric Disease
,
Private Securities Litigation Reform Act
,
Annual Report
,
comparemela.com © 2020. All Rights Reserved.